Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab.
Gil-Delgado MA, Lucidarme O, Bachet JB, Mahi N, Khayat D. Gil-Delgado MA, et al. Among authors: lucidarme o. Case Rep Gastroenterol. 2018 Aug 31;12(2):532-539. doi: 10.1159/000490906. eCollection 2018 May-Aug. Case Rep Gastroenterol. 2018. PMID: 30283289 Free PMC article.
FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial.
Bachet JB, Lucidarme O, Levache CB, Barbier E, Raoul JL, Lecomte T, Desauw C, Brocard F, Pernot S, Breysacher G, Lagasse JP, Di Fiore F, Etienne PL, Dupuis OJM, Aleba A, Lepage C, Taieb J; for FFCD 1102 investigators. Bachet JB, et al. Among authors: lucidarme o. Eur J Cancer. 2018 Nov;104:108-116. doi: 10.1016/j.ejca.2018.09.006. Epub 2018 Oct 18. Eur J Cancer. 2018. PMID: 30343254 Clinical Trial.
Unusual hepatic lesion in a patient with a lung tumor.
Ben Hassen W, Wagner M, Lucidarme O. Ben Hassen W, et al. Among authors: lucidarme o. Gastroenterology. 2014 Jul;147(1):e7-8. doi: 10.1053/j.gastro.2014.02.050. Epub 2014 May 29. Gastroenterology. 2014. PMID: 24880008 No abstract available.
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.
Munteanu M, Pais R, Peta V, Deckmyn O, Moussalli J, Ngo Y, Rudler M, Lebray P, Charlotte F, Thibault V, Lucidarme O, Ngo A, Imbert-Bismut F, Housset C, Thabut D, Ratziu V, Poynard T; FibroFrance Group. Munteanu M, et al. Among authors: lucidarme o. Aliment Pharmacol Ther. 2018 Nov;48(10):1117-1127. doi: 10.1111/apt.14990. Epub 2018 Oct 17. Aliment Pharmacol Ther. 2018. PMID: 30334263 Free PMC article.
RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study.
Lucidarme O, Wagner M, Gillard P, Kim S, Bachet JB, Rousseau B, Mazard T, Louvet C, Chibaudel B, Cohen R, Garcia-Larnicol ML, Gobert A, Henriques J, André T. Lucidarme O, et al. Cancer Imaging. 2019 Dec 9;19(1):85. doi: 10.1186/s40644-019-0271-z. Cancer Imaging. 2019. PMID: 31818317 Free PMC article.
[Initial staging of rectal cancer].
Faouzi I, Lucidarme O. Faouzi I, et al. Among authors: lucidarme o. Rev Prat. 2022 Jan;72(1):38-42. Rev Prat. 2022. PMID: 35258252 French.
123 results